Spectrum Pharma (SPPI) Posts Weaker Q1 Results

May 10, 2010 7:31 AM EDT
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) reports Q1 loss of $0.80, versus the analyst estimate of ($0.15). Revenue for the quarter was $11.1 million, which compares to the estimate of $9.88 million.

You May Also Be Interested In

Related Categories


Add Your Comment